KALV - KalVista Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jul 2019)Next Qtr. (Oct 2019)Current Year (2020)Next Year (2021)
No. of Analysts4464
Avg. Estimate-0.6-0.62-1.57-3.43
Low Estimate-0.66-0.73-3.71-3.83
High Estimate-0.46-0.460.93-3.15
Year Ago EPS-0.47-0.22-1.38-1.57
Revenue EstimateCurrent Qtr. (Jul 2019)Next Qtr. (Oct 2019)Current Year (2020)Next Year (2021)
No. of Analysts2254
Avg. Estimate3.29M3.46M28.15M8.55M
Low Estimate3.07M3.23M10M2.12M
High Estimate3.5M3.7M58.5M16.1M
Year Ago Sales3.72MN/A16.13M28.15M
Sales Growth (year/est)-11.50%N/A74.60%-69.60%
Earnings History7/30/201810/30/20181/30/20194/29/2019
EPS Est.-0.33-0.46-0.45-0.42
EPS Actual-0.47-0.22-0.23-0.49
Difference-0.140.240.22-0.07
Surprise %-42.40%52.20%48.90%-16.70%
EPS TrendCurrent Qtr. (Jul 2019)Next Qtr. (Oct 2019)Current Year (2020)Next Year (2021)
Current Estimate-0.6-0.62-1.57-3.43
7 Days Ago-0.3-0.3-1.46-3.5
30 Days Ago-0.3-0.3-1.46-3.5
60 Days Ago00-1.52-3.5
90 Days Ago00-1.61-3.5
EPS RevisionsCurrent Qtr. (Jul 2019)Next Qtr. (Oct 2019)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/A21
Up Last 30 DaysN/AN/A21
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1132
Growth EstimatesKALVIndustrySectorS&P 500
Current Qtr.-27.70%N/AN/A0.01
Next Qtr.-181.80%N/AN/A0.03
Current Year-13.80%N/AN/A0.04
Next Year-118.50%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A